ImmunityBio, Inc. — Investor Relations & Filings
ImmunityBio, Inc. is a commercial-stage biotechnology company developing next-generation immunotherapies and vaccines designed to strengthen a patient's own immune system. The company's approach focuses on orchestrating both the innate (natural killer cells) and adaptive (T cells) immune systems to combat cancer and infectious diseases. Its key platforms include the IL-15 superagonist Anktiva® (N-803), engineered natural killer (NK) cell therapies, and adenovirus-vectored vaccines. These therapies are being investigated and applied across a range of difficult-to-treat cancers, such as bladder, lung, and pancreatic cancers, as well as infectious diseases like HIV. The company's goal is to create durable, complete responses by treating the host's immune system rather than just the disease.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 8-K | 2026-05-18 | English | |
| 10-Q - ImmunityBio, Inc. (0001326110) (Filer) | 2026-05-07 | English | |
| 8-K - ImmunityBio, Inc. (0001326110) (Filer) | 2026-05-07 | English | |
| 8-K - ImmunityBio, Inc. (0001326110) (Filer) | 2026-04-09 | English | |
| 8-K - ImmunityBio, Inc. (0001326110) (Filer) | 2026-04-06 | English | |
| 8-K - ImmunityBio, Inc. (0001326110) (Filer) | 2026-03-31 | English |
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Cellectar Biosciences, Inc.
Clinical-stage biopharma developing targeted cancer treatme…
|
CLRB | US | Manufacturing |
|
Cellectis
Develops allogeneic, or 'off-the-shelf', CAR T-cell immunot…
|
ALCLS | FR | Manufacturing |
|
Cellid Co., Ltd.
Develops immunotherapeutic vaccines for cancer and infectio…
|
299660 | KR | Manufacturing |
|
Cellromax Science Co., Ltd.
Researches and develops health foods, derma-cosmetics, and …
|
471820 | KR | Manufacturing |
|
CellSeed Inc.
Develops and commercializes cell sheet engineering for rege…
|
7776 | JP | Manufacturing |
|
Celltrion, Inc.
Biopharmaceutical firm developing biosimilars for autoimmun…
|
068270 | KR | Manufacturing |
|
Celltrion Pharm Inc.
Manufactures and supplies chemical pharmaceuticals and bios…
|
068760 | KR | Manufacturing |
|
CELLUMED CO., LTD.
Develops and manufactures medical devices, tissue grafts, a…
|
049180 | KR | Manufacturing |
|
Celon Pharma S.A.
An integrated pharmaceutical company researching and manufa…
|
CLN | PL | Manufacturing |
|
Celularity Inc
Develops allogeneic cell therapies and biomaterials from th…
|
CELU | US | Manufacturing |
ImmunityBio, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/31529/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=31529 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=31529 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=31529 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 31529}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for ImmunityBio, Inc. (id: 31529)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.